VitaSpring Biomedical Co. Ltd. (VSBC) News
Follow VitaSpring Biomedical Co. Ltd. (VSBC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Vitaspring Biomedical posts zero revenue, wider quarterly loss
The company reported third-quarter 2026 revenue of $0 and a net loss of $155,817, versus a loss of $110,845 a year earlier. Diluted EPS was $(0.00).
EQUITY | Sep 17, 2026, 05:34 PM UTC
M
Vitaspring Biomedical appoints Chen CEO, Shih chairman after resignation
The company appointed Jing-Zhou Chen as chief executive officer, president, chief financial officer and secretary, and elected Shao-Hsiang Shih as chairman. The changes followed Dr. Ssu-Chuan Lai’s resignation from multi
EQUITY | Sep 10, 2026, 05:23 PM UTC